Repository logo
 
Publication

Development of bioluminescent Group B streptococcal strains for longitudinal infection studies

dc.contributor.authorLorga, Inês
dc.contributor.authorGeraldo, Rafaela
dc.contributor.authorSoares, Joana
dc.contributor.authorOliveira, Liliana
dc.contributor.authorFiron, Arnaud
dc.contributor.authorBonifácio Andrade, Elva
dc.date.accessioned2025-01-14T10:13:19Z
dc.date.available2025-01-14T10:13:19Z
dc.date.issued2024-10-18
dc.description.abstractGroup B Streptococcus (GBS) remains the leading bacterial cause of invasive neonatal disease, resulting in substantial morbidity and mortality. New therapeutic approaches beyond antibacterial treatment to prevent neonatal disease outcomes are urgent. One significant limitation in studying GBS disease and progression is the lack of non-invasive technologies for longitudinal studies. Here, we develop and compare three bioluminescent GBS strains for in vivo pathogenic analysis. Bioluminescence is based on the luxABCDE operon on a replicative vector (luxGBS-CC17), and the red-shifted firefly luciferase on a replicative vector (fflucGBS-CC17) or integrated in the genome (glucGBS-CC17). We show that luxGBS-CC17 is suitable for in vitro analysis but does not produce a significant bioluminescent signal in infected pups. In contrast, the fflucGBS-CC17 results in a strong bioluminescent signal proportional to the organ colonisation level. However, the stability of the replicative vector depends on the route of infection, especially when pups acquire the bacteria from infected vaginal mucosa. Stable chromosomal integration of luciferase in glucGBS-CC17 leads to significant bioluminescence in both haematological and vertical infection models associated with high systemic colonisation. These strains will allow the preclinical evaluation of treatment efficacy against GBS invasive disease using wholemouse bioluminescence imaging.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationLorga, I., Geraldo, R., Soares, J., Oliveira, L., Firon, A., & Bonifácio Andrade, E. (2024). Development of bioluminescent Group B streptococcal strains for longitudinal infection studies. Scientific Reports, 14(1), 24439. https://doi.org/10.1038/s41598-024-74346-zpt_PT
dc.identifier.doi10.1038/s41598-024-74346-zpt_PT
dc.identifier.eissn2045-2322
dc.identifier.urihttp://hdl.handle.net/10400.22/27092
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherBMCpt_PT
dc.relationThe authors acknowledge Dr. Dzung B. Diep for kindly providing the E. faecalis strain containing the plasmid pSL101P32 and Dr. Joana Tavares for scientific discussion. This work was supported by National Funds through Fundação para a Ciência e a Tecnologia (FCT), I.P., under the projects EXPL/SAU-INF/1217/2021 and 2022.04792.PTDC, and Agence Nationale de la Recherche (VirEvol - ANR-22-CE15-0024). E.B.A and I.L. are supported by FCT (CEECIND/03675/2018 to E.B.A., 2020.05394.BD to I.L.).pt_PT
dc.relation.publisherversionhttps://www.nature.com/articles/s41598-024-74346-zpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectBacteriapt_PT
dc.subjectExperimental models of diseasept_PT
dc.subjectInfectious diseasespt_PT
dc.subjectPaediatric researchpt_PT
dc.titleDevelopment of bioluminescent Group B streptococcal strains for longitudinal infection studiespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleScientific Reports pt_PT
oaire.citation.volume14(1)pt_PT
person.familyNameBonifácio Andrade
person.givenNameElva
person.identifier.ciencia-id511C-11AA-7980
person.identifier.orcid0000-0002-1941-580X
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicatione3b8883f-57b2-4b83-afa1-88e663ed8d1f
relation.isAuthorOfPublication.latestForDiscoverye3b8883f-57b2-4b83-afa1-88e663ed8d1f

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ART_Elva Andrade.pdf
Size:
3.51 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: